1. Home
  2. SONM vs TENX Comparison

SONM vs TENX Comparison

Compare SONM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonim Technologies Inc.

SONM

Sonim Technologies Inc.

N/A

Current Price

$5.00

Market Cap

6.5M

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$11.77

Market Cap

56.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SONM
TENX
Founded
1999
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
56.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SONM
TENX
Price
$5.00
$11.77
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
39.5K
168.4K
Earning Date
10-31-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,109,000.00
N/A
Revenue This Year
$127.68
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.17
N/A
52 Week Low
$4.75
$4.63
52 Week High
$114.84
$11.49

Technical Indicators

Market Signals
Indicator
SONM
TENX
Relative Strength Index (RSI) 35.30 83.61
Support Level $5.85 $10.40
Resistance Level $6.86 $10.55
Average True Range (ATR) 0.47 0.67
MACD -0.18 0.21
Stochastic Oscillator 3.63 97.81

Price Performance

Historical Comparison
SONM
TENX

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: